•
Jun 30, 2019

Biogen Q2 2019 Earnings Report

Total Revenue
$3.62B
Previous year: $3.36B
+7.7%
EPS
$9.15
Previous year: $5.8
+57.8%
Effective Tax Rate
14%
GAAP R&D
$485M
GAAP SG&A
$588M
Gross Profit
$3.14B
Previous year: $2.94B
+7.0%
Cash and Equivalents
$1.72B
Previous year: $1.25B
+37.8%
Free Cash Flow
$1.78B
Previous year: $913M
+94.8%
Total Assets
$26.3B
Previous year: $24B
+9.7%

Biogen

Biogen

Biogen Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income